This move is archived. Current quotes and coverage live on the stock page.
Get AVCR alerts:
Investors showed renewed interest in Avricore Health Inc, driving its stock price up significantly in yesterday's trading session.
Avricore Health Inc (AVCR.V) experienced a notable surge in its stock price yesterday, closing up 9.09% at CA$0.06. This increase reflects growing investor confidence in the company's strategic initiatives and market positioning.
Advertisement
Avricore Health Inc
AVCR.V
AVCR.V
Avricore Health Inc
WealthAwesomeMarket cap
$6.95M
52W high
$0.10
52W low
$0.04
1W change
+27.27%
Beta
0.32
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCR's historical volatility
30-Day Vol
145.8%
Annualized
90-Day Vol
121.1%
Annualized
Trend (90d)
+31.1%
Annualized drift
90d Mean
C$0.08
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.07 | C$0.04 – C$0.12 |
| 60 trading days | C$0.08 | C$0.04 – C$0.15 |
| 90 trading days | C$0.08 | C$0.03 – C$0.19 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: The recent uptick in Avricore Health's stock price may signal a positive shift in investor sentiment, potentially driven by the company's ongoing expansion efforts and financial performance.
Avricore Health's stock price increased by 9.09% yesterday.
With a market cap of approximately CA$7.58 million, Avricore Health's stock movement reflects its relatively small size and the potential for significant price swings.
Bull case
Avricore Health is committed to expanding its HealthTab™ platform, and recent financial results show strong growth potential. The company has reported significant revenue increases, which could attract more investors looking for opportunities in the health tech sector.
Bear case
Despite the recent gains, it's important for investors to stay cautious. The stock's volatility and the lack of major announcements could lead to price fluctuations, highlighting the risks that come with investing in smaller health tech companies.
Recent Performance Overview
Advertisement
Avricore Health Inc's stock price closed at CA$0.06 yesterday, marking a 9.09% increase from the previous day. This surge can be attributed to a combination of positive investor sentiment and the company's ongoing efforts to expand its HealthTab™ platform across various markets.
Strategic Growth Initiatives
The company has been actively working on expanding its HealthTab™ platform, which has already screened over 3,500 patients in community pharmacies across North East London. Such initiatives are crucial for enhancing patient access to care and could drive further growth in the future.
Market Outlook
While the recent surge in stock price is promising, investors should consider the inherent risks associated with smaller companies like Avricore Health. The stock's performance could be influenced by broader market trends and the company's ability to execute its growth strategies effectively.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
